FIP makes it a priority to publish the latest developments in pharmacy practice, pharmaceutical sciences, related global news and prominent events. Our multi-media approach to keeping members, partners and peers informed of what is and will be affecting their area of practice or science is key to keeping information flowing through the FIP network.
FIP makes it a priority to publish the latest developments in pharmacy practice, pharmaceutical sciences, related global news and prominent events. Our multi-media approach to keeping members, partners and peers informed of what is and will be affecting their area of practice or science is key to keeping information flowing through the FIP network.
Lastest Publications
2022Presenting the FIPWiSE 2022 Rising Stars — inspirational women who are making a difference
Twenty women scientists and educators have been selected as FIP’s inaugural Rising Stars for 2022. This article, by Graeme Smith, introduces them and highlights their achievements.
2022Health economics research and deprescribing can benefit pharmacy practice and patients
FIP’s Pharmacy Practice Research Summer Meeting, held in Utrecht, the Netherlands on 4 and 5 July, heard keynote presentations about health economics research and deprescribing. Graeme Smith reports.
2022Pharmacy practice researchers highlight efforts to improve treatments and outcomes for patients
Young scientists described their work in diverse areas at the FIP Pharmacy Practice Research Summer Meeting, which took place in Utrecht, the Netherlands, this month. Graeme Smith reports
This will be a 2-part workshop to introduce the FIP YPG Career Development toolkit. Part 1 will review the toolkit, the available resources, and discuss how it will benefit the user. Attendees will then be instructed to work through the toolkit over the next few weeks.
Part 2 of the workshop will be an engaging session where participants are asked to return with their completed toolkits to discuss what they learned with other attendees, review their toolkits in breakout rooms, and have the opportunity to ask questions.
‘How can digital health support national pharmaceutical care delivery?’ A regional and global assessment of priorities and challenges in the European region
Substandard and falsified medicines, along with a lack of adherence to medication regimens, pose a threat to public health worldwide. It is possible to deliver pharmaceutical care services that address these challenges using digital healthcare techniques and approaches. Globally, digital health faces many challenges and concerns, despite its potential to impact pharmaceutical care. FIP and the Global Pharmaceutical Observatory are launching a new needs assessment programme entitled "How can digital health support national pharmaceutical care delivery? A regional and global assessment of priorities and challenges", with an emphasis on medication adherence and fighting SF medicines. This regional and global needs assessment programme will include a series of six regional events, culminating in a private global roundtable and a summary report.
Aim: Facilitate a regional discussion about ongoing digital health interventions or solutions that detect, report, and act against false or substandard medicines, and how to facilitate patient adherence, as well as the challenges leadership bodies and nations face in implementing digital health solutions in pharmaceutical care delivery in Europe
‘How can digital health support national pharmaceutical care delivery?’ A regional and global assessment of priorities and challenges in the South East Asian region
Substandard and falsified medicines, along with a lack of adherence to medication regimens, pose a threat to public health worldwide. It is possible to deliver pharmaceutical care services that address these challenges using digital healthcare techniques and approaches. Globally, digital health faces many challenges and concerns, despite its potential to impact pharmaceutical care. FIP and the Global Pharmaceutical Observatory are launching a new needs assessment programme entitled "How can digital health support national pharmaceutical care delivery? A regional and global assessment of priorities and challenges", with an emphasis on medication adherence and fighting SF medicines. This regional and global needs assessment programme will include a series of six regional events, culminating in a private global roundtable and a summary report.
Aim: Facilitate a regional discussion about ongoing digital health interventions or solutions that detect, report, and act against false or substandard medicines, and how to facilitate patient adherence, as well as the challenges leadership bodies and nations face in implementing digital health solutions in pharmaceutical care delivery in South East Asia.
‘How can digital health support national pharmaceutical care delivery?’ A regional and global assessment of priorities and challenges in the Americas region
Substandard and falsified medicines, along with a lack of adherence to medication regimens, pose a threat to public health worldwide. It is possible to deliver pharmaceutical care services that address these challenges using digital healthcare techniques and approaches. Globally, digital health faces many challenges and concerns, despite its potential to impact pharmaceutical care. FIP and the Global Pharmaceutical Observatory are launching a new needs assessment programme entitled "How can digital health support national pharmaceutical care delivery? A regional and global assessment of priorities and challenges", with an emphasis on medication adherence and fighting SF medicines. This regional and global needs assessment programme will include a series of six regional events, culminating in a private global roundtable and a summary report.
Aim: Facilitate a regional discussion about ongoing digital health interventions or solutions that detect, report, and act against false or substandard medicines, and how to facilitate patient adherence, as well as the challenges leadership bodies and nations face in implementing digital health solutions in pharmaceutical care delivery in Americas region.
‘How can digital health support national pharmaceutical care delivery?’ A regional and global assessment of priorities and challenges in the Western Pacific region
Substandard and falsified medicines, along with a lack of adherence to medication regimens, pose a threat to public health worldwide. It is possible to deliver pharmaceutical care services that address these challenges using digital healthcare techniques and approaches. Globally, digital health faces many challenges and concerns, despite its potential to impact pharmaceutical care. FIP and the Global Pharmaceutical Observatory are launching a new needs assessment programme entitled "How can digital health support national pharmaceutical care delivery? A regional and global assessment of priorities and challenges", with an emphasis on medication adherence and fighting SF medicines. This regional and global needs assessment programme will include a series of six regional events, culminating in a private global roundtable and a summary report.
Aim: Facilitate a regional discussion about ongoing digital health interventions or solutions that detect, report, and act against false or substandard medicines, and how to facilitate patient adherence, as well as the challenges leadership bodies and nations face in implementing digital health solutions in pharmaceutical care delivery in the Western Pacific.
Asthma and chronic obstructive pulmonary disease are two common chronic respiratory diseases that affect hundreds of millions of people worldwide. Pharmacists have an important role to play in their prevention, care and management. FIP has developed a new handbook to support pharmacists and their organisations in providing a range of chronic respiratory diseases-related services. This handbook — which will be launched at this event — also identifies the knowledge and skills that pharmacists require for the provision of such services, thus offering guidance to academic institutions and CPD providers. This handbook is part of the FIP Practice Transformation Programme on Non-Communicable Diseases.
Learning objectives:
Explore the role of pharmacists in the prevention, care and management of chronic respiratory diseases and its complications;
Identify the challenges and opportunities for pharmacists in addressing chronic respiratory diseases;
Identify the relevant knowledge and skills required for the delivery of chronic respiratory diseases-related services.
Cancer is the second leading cause of death globally, accounting for 9.6 million deaths, according to the World Health Organization. Pharmacists have a role to play in ensuring the prevention, in supporting patients to undergo frequent screening or even collaborate in screening campaigns for certain types of cancer, in managing oncological medication for optimal outcomes, in supporting self-care and the management of symptoms that some treatments might cause and in providing emotional support. FIP has developed a new handbook to support pharmacists and their organisations in providing a range of cancer-related services. This handbook — which will be launched at this event — also identifies the knowledge and skills that pharmacists require for the provision of such services, thus offering guidance to academic institutions and CPD providers. This handbook is part of the FIP Practice Transformation Programme on Non-Communicable Diseases.
Learning objectives:
Explore the role of pharmacists in the prevention, care and management of cancer;
Identify the challenges and opportunities for pharmacists in addressing cancer;
Identify the relevant knowledge and skills required for the delivery of cancer-related services.
The fuel behind the advancement of precision medicine is the rapid growth of underlying technologies, from high-throughput sequencing and imaging to machine learning and clinical decision support systems. What are the cutting-edge technologies and fields, and what trends can we expect in the future?
The webinar will cover:
- Ongoing technological developments
- Examples of clinical application of the above technologies in a research context
- Thoughts on future directions of the field, and unaddressed gaps
- Changes to pharmacy education that are needed for future pharmacists to be competent in implementing precision medicine practices effectively
- Gaps and challenges in the field that pharmacists and pharmaceutical scientists could address
The World Health Organization estimate that 17.9 million people die from cardiovascular diseases each year, representing 32% of all global deaths. Pharmacists have a role to play in the prevention, care and management of cardiovascular diseases and their complications. FIP has developed a new handbook to support pharmacists and their organisations in providing a range of cardiovascular diseases-related services. This handbook — which will be launched at this event — also identifies the knowledge and skills that pharmacists require for the provision of such services, thus offering guidance to academic institutions and CPD providers. This handbook is part of the FIP Practice Transformation Programme on Non-Communicable Diseases.
Learning objectives:
Explore the role of pharmacists in the prevention, care and management of cardiovascular diseases and their complications;
Identify the challenges and opportunities for pharmacists in addressing cardiovascular diseases;
Identify the relevant knowledge and skills required for the delivery of cardiovascular diseases-related services.
Among the greatest bottlenecks for the widespread implementation of precision medicine is the growing costs of the associated technologies. It also brings new challenges for health technology assessment, with cost-utility becoming more difficult to evaluate and predict at finer levels of patient stratification. What are these challenges? How could we address them? How might we go about refining precision medicine strategies to maximize cost utility?
The webinar will cover:
- The current health technology assessment stance on precision medicine applications
- What we know and what we don’t know about the cost-utility of new precision medicine approaches against the standard of care
- How costs may evolve with emerging technologies or trends
- Priorities for future health economics research in this area
The first of December commemorates World AIDS day and this year FIP will join this campaign by launching a toolkit for pharmacists on HIV prevention, screening and management. It is now possible to effectively prevent the transmission of HIV through pharmacological strategies (preexposure and postexposure prophylaxis). New HIV tests have also become available, including point-of-care tests and self-tests. Pharmacists’ expertise and accessibility can be leveraged for a variety of important roles in the prevention and screening of HIV infections. Join this event to learn about these roles and be inspired by examples from different countries.
By the end of the session participants should be able to:
Understand the roles pharmacists can play in HIV prevention, screening and management
Recognise some resources and tools that pharmacists can use in this area
Find and use the FIP toolkit on HIV prevention, screening and management